Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing and eliminating these disparities will improve ...
American Society of Echocardiography (ASE) guidelines for echocardiographic evaluation of aortic regurgitation (AR) were found to “display very good performance” in detecting significant AR, according ...
The U.S. Food and Drug Administration (FDA) posted a letter to health care providers on Nov. 15, announcing that Getinge/Maquet has issued an Urgent Medical Device Removal notice warning against use ...
The 2024 multisociety Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD) highlights the implementation of the PAD National Action Plan as a critical advocacy priority, ...
In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves. He then explores complete vs ...
Intraoperative His bundle mapping is safe and required a median mapping time of 6 minutes. Postoperative atrioventricular block requiring pacemaker (AVB/PM) frequency was significantly reduced with ...
Completing (or Continuing) Your Training? Let's Stay in Touch! During and just after your training, the right support is critical. Ensure we're providing you with support tailored to your needs. If ...
Among patients at high risk of stroke or systemic embolism, the AMPLATZER Amulet left atrial appendage (LAA) occluder was as safe and effective as the Watchman 2.5 device at five-year follow-up, ...
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to new research published in JACC and simultaneously presented at AHA 2024. Among the highlights: ...
Patel R, Wadid M, Makwana B, et al. This was a retrospective, observational cohort study of 29,922 patients ≥18 years old, diagnosed with T2DM, BMI of ≥27 kg/m 2, and documented history of HFpEF (left ...
Advances in lipid therapeutics were the focus of a late-breaking science session at AHA 2024, with researchers presenting findings evaluating the safety of the novel new drug muvalaplin in lowering ...